Clinical Trials Browser

NETWORK × Ovarian Neoplasms × Fenretinide × Clear all

NCT01535157 2020-08-27

Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer

Phase 1/2 Terminated

Ovarian Neoplasms

NCT00017134 2013-06-10

Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk

Phase NA Terminated

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms